Summary of COVID-19 elderberry studies

1. Evans et al., A Randomised, Single Blinded Study Investigating the Role of ' Black Elderberry (Sambucus Nigra) (Sambucol®) in the Treatment, Progression and Reduction of Symptoms in Participants With Coronavirus 19

204 patient elderberry early treatment RCT: 1% worse recovery (p=0.37).
RCT 204 COVID-19 patients showing no significant differences with Sambucol® black elderberry (Sambucus nigra) treatment. Treatment delay is unknown and may be too late. There was no restriction on the time from symptom onset, patients only needed a positive test result within the last 5 days.
May 2022, NCT05489770, https://clinicaltrials.gov/study/NCT05489770, https://c19p.org/evans4